HonCode

Go Back   HER2 Support Group Forums > Articles of Interest
Register Gallery FAQ Members List Calendar Search Today's Posts Mark Forums Read

Reply
 
Thread Tools Display Modes
Old 01-10-2023, 03:41 PM   #1
Nguyen
Senior Member
 
Join Date: Nov 2005
Posts: 440
Phase II neoadjuvant trial evaluating trastuzumab deruxtecan with or without anastroz

https://ascopubs.org/doi/abs/10.1200...5_suppl.TPS603

TRIO-US B-12 TALENT: Phase II neoadjuvant trial evaluating trastuzumab deruxtecan with or without anastrozole for HER2-low, HR+ early stage breast cancer.


https://www.onclive.com/view/trastuz...-breast-cancer

Trastuzumab Deruxtecan, With or Without Endocrine Therapy, Shows Promising Responses in Operable HR+, HER2-Low Breast Cancer

"...Additionally, the study demonstrated that trastuzumab deruxtecan yielded dynamic changes in HER2 tissue expression; 48.6% of patients (n = 17) experienced a change in HER2 IHC expression after trastuzumab deruxtecan treatment. Among patients who experienced a change, 88.2% had a decrease in HER2 expression between baseline and surgery—this included a subset of patients with HER2 IHC-0 disease...."
Nguyen is offline   Reply With Quote
Reply

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is On

Forum Jump


All times are GMT -7. The time now is 12:53 AM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2023, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter